Local News Massachusetts General Hospital Selects Varian Radiotherapy Systems for Cancer Center BioSpace | February 3, 2020 Varian (NYSE: VAR) today announced it has signed an agreement with Massachusetts General Hospital to provide seven Varian…sciencecityFebruary 3, 2020 Read More
Local News Cambridge Biotech Tripling Size of Kendall Square HQ Boston Business Journal | February 3, 2020 Cambridge-based Foghorn Therapeutics plans to expand into a new 60,000-square-foot headquarters at 500 Technology Square…sciencecityFebruary 3, 2020 Read More
Local News Genetic Screen Offers New Drug Targets for Huntington’s Disease MIT Picower Institute | February 3, 2020 Using a type of genetic screen that had previously been impossible in the mammalian brain,…sciencecityFebruary 3, 2020 Read More
Local News Dana-Farber Opens New Facility in Merrimack Valley Dana-Farber Cancer Institute | February 3, 2020 Following a festive ribbon cutting earlier this week, Dana-Farber Cancer Institute is opening a new site this…sciencecityFebruary 3, 2020 Read More
Local News Good Early Results with Gene Therapy for Rare Immune Deficiency Boston Children's Hospital | January 31, 2020 Brenden Whittaker, a college student in Ohio, has been caught off guard by his good…sciencecityJanuary 31, 2020 Read More
Local News Engineers Design Bionic “Heart” for Testing Prosthetic Valves, Other Cardiac Devices MIT News | January 31, 2020 As the geriatric population is expected to balloon in the coming decade, so too will…sciencecityJanuary 31, 2020 Read More
Local News Gift Will Allow MIT Researchers to Use Artificial Intelligence in a Biomedical Device MIT News | January 31, 2020 Researchers in the MIT Department of Civil and Environmental Engineering (CEE) have received a gift…sciencecityJanuary 31, 2020 Read More
Local News Bone Marrow-on-a-Chip Provides New Research Directions for Shwachman-Diamond Syndrome Boston Children's Hospital | January 30, 2020 A new research tool that mimics the behavior of diseased bone marrow provides a new…sciencecityJanuary 30, 2020 Read More
Local News EyePoint Pharmaceuticals and Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize DEXYCU® for Post-operative Inflammation in Mainland China, Hong Kong, Macau and Taiwan BioSpace | January 30, 2020 EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, and…sciencecityJanuary 30, 2020 Read More
Local News 100 Years after the Advent of TB Vaccines, Formulations Vary Widely Boston Children's Hospital | January 30, 2020 Each year, more than 100 million newborns around the world receive vaccinations against Mycobacterium tuberculosis, or…sciencecityJanuary 30, 2020 Read More